Colgate-Palmolive Company (NYSE:CL) is included among the 11 Best Rising Dividend Stocks to Buy Right Now.
On May 5, Barclays raised its price recommendation on Colgate-Palmolive Company (NYSE:CL) to $80 from $79. It reiterated an Equal Weight rating on the shares. The firm said it believes the company is focusing on achieving a better balance between pricing and volume growth in 2026.
A few days earlier, on May 2, Goldman Sachs raised its price goal on Colgate-Palmolive to $100 from $98. It maintained a Buy rating on the stock. The firm pointed to the company’s stronger-than-expected Q1 results, with both revenue and earnings coming in ahead of expectations. According to the analyst, organic sales growth was higher than anticipated, while broad-based strength across the business also supported slightly better-than-expected gross margins. Goldman Sachs added that EBIT margins remained in line with expectations even as advertising spending increased 10% during the quarter.
Colgate-Palmolive Company (NYSE:CL) focuses on oral care, personal care, home care, and pet nutrition products.
While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Micro-Cap Dividend Stocks To Buy Now and 10 Best Stocks to Buy Now for a $1 Million Portfolio
Disclosure: None. Follow Insider Monkey on Google News.
